Efficacy and Safety of Vonorasan Versus Esomeprazole in the Treatment of Ulcers After Endoscopic Submucosal Dissection

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

196

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

June 30, 2029

Study Completion Date

June 30, 2029

Conditions
Ulcers, Gastric
Interventions
DRUG

Vonoprazan

oral drug 3-56 days after ESD.

DRUG

Esomeprazole

oral drug 3-56 days after ESD.

Trial Locations (4)

Unknown

The First Affiliated Hospital of Jinan University, Guangzhou

The First Hospital of Guangzhou Medical University, Guangzhou

Maoming People's Hospital, Maoming

Yellow River Sanmenxia Hospital, Sanmenxia

All Listed Sponsors
collaborator

First Affiliated Hospital of Jinan University

OTHER

collaborator

The First Affiliated Hospital of Guangzhou Medical University

OTHER

collaborator

Maoming People's Hospital

OTHER

collaborator

Yellow River Sanmenxia hospital

UNKNOWN

lead

Shicai Ye

OTHER

NCT06526455 - Efficacy and Safety of Vonorasan Versus Esomeprazole in the Treatment of Ulcers After Endoscopic Submucosal Dissection | Biotech Hunter | Biotech Hunter